The acquisition marks Sawai’s first overseas acquisition in the company’s 88-year history, according to the report.
“Upsher-Smith has a very good eye on selecting products and pricing them to a level [that] can bring sufficient profit to the company,” Sawai President Mitsuo Sawai told Bloomberg. “We have manufacturing technology that enables us to bring down cost and want to combine it.”
Upsher-Smith’s non-generic business is not included in the deal, which is expected to close next month.
More articles on supply chain:
Pharma spent $78M on lobbying so far this year: 4 statistics
Dr. Scott Gottlieb talks drug price strategies, FDA hiring freeze: 4 takeaways
Novartis receives expanded approval for lung cancer drug
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
